Sangon Biotech

Shanghai, China Founded: 2003 • Age: 23 yrs
Research services, reagents, and kits for biotech applications are provided.

About Sangon Biotech

Sangon Biotech is a Healthcare company based in Shanghai (China) founded in 2003. Research services, reagents, and kits for biotech applications are provided. Sangon Biotech has raised $300 million across 2 funding rounds from investors including CITIC Capital, Qiming Venture Partners and Greenwoods Investments. Its website sangon.com draws about 227 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents.

Company details

Sangon Biotech was founded in 2003 and is based in Shanghai, China. Operations focus on the biotechnology sector, where services such as oligonucleotide, gene, and peptide synthesis are delivered. DNA and next-generation sequencing, along with protein, antibody, and molecular biology services, are also offered. Reagents including PCR and enzymes, plus ELISA and PCR kits, are supplied to support research activities.

  • Headquarters Shanghai, China
  • Sectors
    Healthcare
  • Website category Science and Education · Biology
  • Website sangon.com
  • Social LinkedIn
Key Metrics
  • Total Equity Funding
    $300M (USD)

    in 2 rounds

  • Latest Funding Round
    $290M (USD), Series B

    Apr 2023

  • Investors

Funding Insights of Sangon Biotech

Sangon Biotech has successfully raised a total of $300M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $290 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $300M
  • Total Rounds 2
  • Last Round Series B β€” $290M
  • First Round $10M

    (Aug 2010)

  • Investors Count 8

All 2 funding rounds of Sangon Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2023$290MSeries B–Greenwoods Investments, Gl-investment
Aug 2010$10MSeries A––
Valuation history

8 investors in total: 8 institutional.

Investors in Sangon Biotech

Sangon Biotech has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include CITIC Capital, Qiming Venture Partners and Greenwoods Investments.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
greenwoodsinvest.com
Acquisitions are targeted by CPE as a private equity firm.
cpe-fund.comBeijing, China
Private equity investment firm focused on multiple sectors
huagaicapital.comDongguan, China
Private equity and venture capital fund focused on the healthcare sector
novoholdings.dkHellerup, Denmark
Venture capital investments are directed toward multiple sectors.
2006qimingvc.comShanghai, China
GL Capital is focused on healthcare sector value investments.
gl-investment.comBeijing, China
cdb-vc.com
Commercial ecological platform projects are targeted by this corporate fund.
2002citiccapital.comHong Kong, China
Premium access

Investor details for Sangon Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Sangon Biotech

3 dated milestones of Sangon Biotech across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sangon Biotech is founded.
  2. Funding First funding round of $10.0M.
  3. Funding Latest funding round, Series B, of $290.0M.

Web traffic of Sangon Biotech

The website of Sangon Biotech (sangon.com) receives about 226.9K visits a month and ranks #101,937 among all websites worldwide, #6,524 in Biology.

  • Monthly visits
    226.9K

    ▼ 27.2% vs previous month

  • Unique visitors
    75.9K

    per month

  • Global rank
    #101,937

    among all websites

  • Category rank
    #6,524

    Science and Education · Biology

Similar websites

Websites whose visitors overlap most with Sangon Biotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
beyotime.com
beyotime.com
100%
–
yeasen.com
80%
69K#449,589View details
sigmaaldrich.cn
72%
#173,967View details
medchemexpress.cn
medchemexpress.cn
72%
#58,858–
takara.com.cn
takara.com.cn
71%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Sangon Biotech

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sangon Biotech

Premium access

Complete news archive for Sangon Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangon Biotech

Sangon Biotech was founded in 2003 and raised its 1st funding round 7 years after it was founded.

Sangon Biotech is headquartered in Shanghai, China.

Sangon Biotech is a funded company, having raised a total of $300M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Aug 2010.

Sangon Biotech was founded in 2003 and is based in Shanghai, China. Operations focus on the biotechnology sector, where services such as oligonucleotide, gene, and peptide synthesis are delivered. DNA and next-generation sequencing, along with protein, antibody, and molecular biology services, are also offered. Reagents including PCR and enzymes, plus ELISA and PCR kits, are supplied to support research activities.

Sangon Biotech has 8 investors. Key investors include CITIC Capital, Qiming Venture Partners, Greenwoods Investments, CPE, and GL Capital.

The website of Sangon Biotech receives about 227 thousand visits a month and ranks #101,937 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available